Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.

Research Article
Volume 5 Issue 4 - 2020
Glycemic Profile of Indian Patients Receiving Hydroxychloroquine
Mohamed Iliyas1,2*, Sundaramurthy Ganesan2, Rajeswari Sankaralingam3 and Alagu Thiyagarajan4
1Institute of Cardiology, Madras Medical College, Chennai, India
2Institute of Internal Medicine, Madras Medical College, Chennai, India
3Department of Rheumatology, Shri Ramachandra Medical College and Research Institute, Chennai, India
4Department of General Medicine, Coimbatore Medical College, Coimbatore, India
*Corresponding Author: Mohamed Iliyas, Institute of Cardiology and Institute of Internal Medicine, Madras Medical College, Chennai, India.
Received: March 04, 2020; Published: March 17, 2020


Background and Aims: Hydroxychloroquine (HCQ) is a Disease Modifying Antirheumatic Drug (DMARD) known to produce hypoglycemia, widely used in Rheumatology. The anti-diabetic and anti-atherosclerotic effects of HCQ is a novel area of interest. The aim of this study was to identify the effect of hydroxychloroquine on blood glucose levels in Indian patients with rheumatological diseases.

Material and Method: A prospective observational study was conducted in the Institute of Rheumatology, Madras Medical College. 100 successive patients newly diagnosed with a rheumatological disease were selected. Baseline Glycated hemoglobin (HbA1c), fasting and postprandial blood sugar levels were measured and compared after 3 months of treatment with Hydroxychloroquine at a dose of 200 mg once daily. Efficacy was assessed by the changes in HbA1c, fasting and postprandial blood glucose levels after 3 months. Based on the results they were classified as diabetes mellitus (DM), impaired glucose tolerance (IGT) and normal glucose tolerance (NGT) as recommended by American Diabetes Association [1]. The results were analyzed by paired t test.

Results: Out of 100 cases, 30 cases (30%) fell into DM group, 30 cases (30%) in IGT and 40 cases (40%) in NGT. In the DM group pre and post HCQ HbA1c levels were 6.75% and 6.39%, in the IGT group it was 6.24% and 5.95% while in the NGT group it was 6.24% and 5.95% respectively.

Conclusion: Hydroxychloroquine had greater effect in decreasing blood glucose level in patients with Diabetes Mellitus compared to those with Impaired and Normal glucose tolerance.

Keywords: Diabetes Mellitus; Glycated Hemoglobin; Hydroxychloroquine; Rheumatoid Arthritis; Systemic Lupus Erythematosus


  1. “Diagnosis and classification of diabetes mellitus. American Diabetes Association”. Diabetes Care 35.1 (2012): S64-S71.
  2. Ramachandran A., et al. “Diabetes in Asia”. Lancet 375.9712 (2010): 408-418.
  3. Ramachandran A and Snehalatha C. “Current scenario of diabetes in India”. Journal of Diabetes 1.1 (2009): 18-28.
  4. Wozniacka A., et al. “Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit”. Lupus 11.2 (2002): 71-81.
  5. Sperber K., et al. “Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1) and IL-6 in human monocytes and T cells”. Journal of Rheumatology 20.5 (1993): 803-808.
  6. Van den Borne B., et al. “Chloroquine and hydroxychloroquine equally affect tumor necrosis factor interleukin 6 and interferon production by peripheral blood mononuclear cells”. Journal of Rheumatology 24.1 (1997): 55-60.
  7. McChesney E., et al. “Studies on the metabolism of some compounds of the 1-amino-7-chloroquinoline series”. Journal of Pharmacology and Experimental Therapeutics 151.3 (1966): 482.
  8. Quatraro A., et al. “Hydroxychloroquine in decompensated, treatment-refractory noninsulin -dependent diabetes mellitus: a new job for an old drug?” Annals of Internal Medicine 112.9 (1990): 678-681.
  9. Blazar B., et al. “In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance”. Diabetes 33.12 (1984): 1133-1136.
  10. Wasko MC., et al. “Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis”. Journal of the American Medical Association 298.2 (2007): 187-193.
  11. Ben-Zvi I., et al. “Hydroxy Chloroquine: from malaria to autoimmunity”. Clinical Reviews in Allergy and Immunology 42.2 (2012): 145-153.
Citation: Mohamed Iliyas., et al. “Glycemic Profile of Indian Patients Receiving Hydroxychloroquine”. EC Endocrinology and Metabolic Research 5.4 (2020): 09-15.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.